Venari Medical announces publication of pre-clinical data in

/PRNewswire/ -- InVera Medical are delighted to announce the publication of its pre-clinical feasibility study of the InVera minimally invasive, exclusively

VUMC Research Resources Department of Orthopaedic Surgery

enVVeno Medical (NVNO) Stock: Unique Exposure To Venous Treatment Domain

Safety and Diagnostic Efficacy of Gadobenate Dimeglumine in MRI of the Brain and Spine of Neonates and Infants

Latest news – BIBA Medtech Insights

TechFem Fridays - New foetal abnormality tests, workplace-supporting women's health companies & Natural Cycles in the spotlight

How to stimulate big ideas in healthcare

Prospective Clinical Trial Registration: A Prerequisite for Publishing Your Results

TechFem Fridays - New foetal abnormality tests, workplace-supporting women's health companies & Natural Cycles in the spotlight

Bridging clinical and real-world data

Venari Medical: Galway medtech with a potentially life-changing device - MedTech Innovator

Venari Medical announces publication of pre-clinical data in leading scientific journal Phlebology and changes name to InVera Medical™

Myocardial Injury After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria - ScienceDirect

InVera Medical (@InVeraMedical) / X

Ivera Medical - Crunchbase Company Profile & Funding